Robbins LLP Is Investigating the Officers and Directors of Corium International, Inc. (CORI) on Behalf of Shareholders
Robbins LLP is investigating whether certain officers and directors of Corium International, Inc. (NASDAQGM: CORI) breached their fiduciary duties to shareholders. Corium is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of specialty pharmaceutical products.
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.